Cyclophosphamide stimulates lung fibroblasts to release neutrophil and monocyte chemoattractants

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 6 24-6, 2001, Pages

  Koyama, Sekiya ^a,b   Takamizawa, Akemi ^b   Sato, Etsuro ^b   Masubuchi, Takeshi ^b   Nagai, Sonoko ^c   Izumi, Takateru ^c  

^a Matsumoto Hospital   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Granulocyte colonystimulating factor; Granulocyte macrophage colony stimulating factor; Interleukin 8; Interstitial lung disease; Monocyte chemoattractant protein 1

Indexed keywords

CYCLOHEXIMIDE; CYCLOPHOSPHAMIDE; CYTOKINE ANTIBODY; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; INTERLEUKIN 8; INTERLEUKIN 8 ANTIBODY; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LIPOXYGENASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; INTERSTITIAL LUNG DISEASE; LUNG FIBROBLAST; LUNG TOXICITY; MONOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; TOXICOKINETICS;

EID: 0034991488     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.6.l1203     Document Type: Article

References (31)

1. Role of monocytes and interstitial cells in the generation of alveolar macrophages. II. Kinetic studies after carbon loading
2. Pulmonary toxicity of antineoplastic drugs
3. A quantitative evaluation of pulmonary macrophage kinetics
4. Isolation of mononuclear cells and granulocytes from human blood
5. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs
6. Alveolitis during procarbazine, vincristine and cyclophosphamide therapy
7. A 48-well microchemotaxis assembly for rapid and accurate measurement of leukocyte migration
8. The pulmonary toxicity of anti-neoplastic agents
9. Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization
10. Pathogenesis of the granulomatous lung disease
11. Randomised controlled trial comparing prednisolone in combination in cryptogenic fibrosis alveolitis
12. Pulmonary fibrosis after prolonged treatment with low-dose cyclophosphamide
13. Alveolar type II-like cells release G-CSF as neutrophil chemotactic activity
14. Human lung fibroblasts release chemokinetic activity for monocytes constitutively
15. Production of monocyte chemotactic and activating factor (MCAF) by human dermal fibroblasts in response to interleukin 1 or tumor necrosis factor
16. Induction of membrane associated interleukin-1 by tumor necrosis factor in human fibroblasts
17. Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts. I. Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factor
18. Cyclophosphamide pneumonitis
19. The granulocyte-macrophage colony-stimulating factors
20. Pulmonary toxicity of cyclophosphamide: A 1-year study
21. Assessment of leukotriene B4 synthesis in human lymphocytes by using high performance liquid chromatography and radioimmunoassay methods
22. The human homolog of the JE gene encodes a monocyte secretory protein
23. Macrophages and polymorphonuclear neutrophils in lung defense and injury
24. Early-onset cyclophos-phamide-induced interstitial pneumonitis
25. Interleukin-8 gene expression by a pulmonary epithelial cells. A model for cytokine networks in the lung
26. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta
27. Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts
28. Bleomycin stimulates human lung fibroblasts to release neutrophil and monocyte chemotactic activity
29. Chemotactic activity of recombinant human granulocyte colony-stimulating factor
30. Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor
31. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor